Pfenex (PFNX) Tops Q3 EPS by 13c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/13/2026

1. MIRM
2. SPY
3. META
4. MSFT
5. JNJ
6. PLTR
7. HUM
8. NVDA
9. CSCO
10. KTOS

Go back to Pfenex (PFNX) Tops Q3 EPS by 13c

Pfenex Reports Third Quarter 2015 Results and Provides Business Update

November 13, 2015 8:00 AM EST

SAN DIEGO, Nov. 13, 2015 /PRNewswire/ -- Pfenex Inc. (NYSE MKT: PFNX), a clinical-stage biotechnology company engaged in the development of biosimilar therapeutics, including high value and difficult to manufacture proteins, today reported financial results for the third quarter ended September 30, 2015 and provided a business update.

"Pfenex has made significant progress in advancing its portfolio of biosimilar product candidates in the third quarter," stated Bertrand C. Liang, chief executive officer of Pfenex.  "Today we are pleased to provide an... More